NCT06803459

Brief Summary

Upper crossed syndrome (UCS) is a condition threatening the physical health, anxiety level and quality of life of university students. Despite biomechanical and neurological approaches are available, evidence on their practicality and effectiveness remained scarce among university students. This randomized controlled trial aimed to determine the effectiveness of Baduanjin and Proprioceptive neuromuscular facilitation (PNF) on symptoms of UCS in university students in Henan Province, China. A total of 90 university students with crossed syndrome will be recruited and randomised into intervention (Baduanjin and PNF) and control groups. The intervention groups will undergo a structured exercise therapy or PNF for 12 weeks. The primary outcomes are improvement on neck range of motion and static posture while secondary outcomes are perceived Quality of Life (QoL) and level of anxiety.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 9, 2024

Completed
6 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 15, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2024

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

January 26, 2025

Completed
5 days until next milestone

First Posted

Study publicly available on registry

January 31, 2025

Completed
Last Updated

January 31, 2025

Status Verified

October 1, 2024

Enrollment Period

6 days

First QC Date

January 26, 2025

Last Update Submit

January 26, 2025

Conditions

Keywords

UCS

Outcome Measures

Primary Outcomes (6)

  • Static posture

    Static postures are divided into Forward Head Angle and Forward Shoulder Angle.

    12 weeks

  • Cervical range of motion (CROM)

    Head forward, head back, head left, head right, head left rotation and head right rotation.

    12 weeks

  • Pain

    Numeric Pain Rating Scale (NPRS)

    12 weeks

  • Neck disorder

    Neck Disability Index

    12 weeks

  • Anxiety

    Self-rating Anxiety Scale

    12 weeks

  • Quality of life

    SF-12 scale

    12 weeks

Study Arms (3)

Baduanjin

EXPERIMENTAL

This will be an experiment of about 60 minutes three times a week for 12 weeks.

Other: BaduanjinOther: PNF

PNF

EXPERIMENTAL

This will be an experiment of about 60 minutes three times a week for 12 weeks.

Other: BaduanjinOther: PNF

Control Group

NO INTERVENTION

The subjects performed daily activities for 12 weeks.

Interventions

36 times.

BaduanjinPNF
PNFOTHER

36 times.

BaduanjinPNF

Eligibility Criteria

Age18 Years - 23 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • (1) FHA≥42°; (2) FSA≥49°; (3) Recurrent neck pain accompanied by dizziness and headache for ≥2 months; (4) Chest tightness, easy to panic, dyspnea. Severe cases with dizziness and headache; (5) The neck head is too long at the desk or the pain is aggravated after fatigue; (6) Tenderness and/or spasms in the neck and shoulder; (7) Neck and back muscles are tense and stiff, and neck motion is limited.

You may not qualify if:

  • (1) Meet the above diagnostic criteria; (2) University students aged 18-23, male or female; (3) No other treatment and no other physical activities during the treatment; (4) Able to complete the whole rehabilitation program as planned; (5) Sign informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Zhengzhou Normal University

Zhengzhou, Henan, 450000, China

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
students

Study Record Dates

First Submitted

January 26, 2025

First Posted

January 31, 2025

Study Start

October 9, 2024

Primary Completion

October 15, 2024

Study Completion

November 30, 2024

Last Updated

January 31, 2025

Record last verified: 2024-10

Locations